deltatrials
Terminated PHASE3 INTERVENTIONAL 2-arm NCT00388804

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

Randomized Trial of External Beam Radiation With or Without Short-Course Hormonal Therapy in Intermediate Risk Prostate Cancer Patients

Sponsor: M.D. Anderson Cancer Center

Updated 7 times since 2017 Last updated: Jun 29, 2012 Started: Feb 28, 2005 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Slow accrual.

A PHASE3 clinical study on Prostate Cancer, this trial is terminated or withdrawn. The trial is conducted by M.D. Anderson Cancer Center and has accumulated 7 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotTerminated~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2022 · 23 months · monthly snapshotTerminated~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotTerminated~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

7 versions recorded
  1. Sep 2024 — Present [monthly]

    Terminated PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Terminated PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Terminated PHASE3

  5. Jan 2021 — Dec 2022 [monthly]

    Terminated PHASE3

Show 2 earlier versions
  1. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE3

  2. Jan 2017 — Jun 2018 [monthly]

    Terminated PHASE3

    First recorded

Feb 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • M.D. Anderson Cancer Center
Data source: M.D. Anderson Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations